
|
|
||||
26.PSYCHO-ONCOLOGY DIVISION |
||||
|
|
||||
Psycho-Oncology has focused on two aspects of cancer; the psychosocial impacts of cancer on the quality of life (QOL) of the patient, family and staff, and the role that psychosocial and behavioral factors may play in cancer risk and survival. Established in September 1995, the Psycho-Oncology Division has focused on the psycho-social impacts of cancer on patient QOL, especially depression.
Depression in Cancer Patients
Depression is well known to be among the most common expressions of psychological distress in cancer patients (314). Despite the high prevalence of depression in cancer patients, it is poorly recognized and not appropriately treated (315). To clarify the clinical course of depression in non-small cell lung cancer (NSCLC) patients during the year after surgery and to identify predictors of their long-term outcome, a total of 212 patients completed assessments during a 12-month follow-up period after curative resection of NSCLC (316,317). The prevalence of depression did not change during the year after curative resection (4.7-8.0%). A depression episode at 1 month after surgery and "less educated" were significant predictors of depression at 12 months. These results suggest the need for psychosocial support even after curative resection of NSCLC and that an approach which includes postoperative assessment of depression and careful attention to less educated patients might be of benefit to patients in ameliorating depression during the year after curative resection. Other Psychological Distress in Cancer Patients
Having cancer is extremely stressful, and distressing cancer-related recollections, one of the PTSD symptoms, are frequently reported by medical staff as well as cancer survivors (319). Smaller left hippocampal volume was observed in breast cancer survivors with distressing cancer-related recollections, which is consistent with the hippocampal findings in patients with stress-related neuropsychiatric disorders, such as PTSD and depression. To examine further the relationship between distressing cancer-related recollections and emotional memory consolidation in breast cancer survivors, the amygdale volume was examined using 3-D MRI imaging (320). The volume of the left amygdale, but not the left hemisphere, was significantly smaller (5.7%) in the subjects with a history of distressing cancer-related recollections (N=35) than in those without any such history (n=41). the results suggested that having distressing cancer-related recollections is associated with the left amygdale as well as the left hippocampus in survivors of breast cancer. A longitudinal study is ongoing to elucidate when amygdale and hippocampal alterations occur. Refractory Symptoms in Advanced CancerCancer patients frequently suffer from a myriad of symptoms (326-329). Fatigue and dyspnea are one of the most frequent and refractory symptoms in cancer patients. To use a concise assessment tool, the Japanese version of the Brief Fatigue Inventory was examined. The results suggested that this scale is a brief, valid, reliable and feasible measure of fatigue for use with Japanese cancer patients (330). The development of the comprehensive assessment tool is essential to the effective management of these symptoms. The results suggested that the MD Anderson Symptom Inventory is a brief, valid, and reliable tool for Japanese cancer patients (331). These assessment scales represent a first step in the therapeutic strategy to reduce pain and other refractory symptoms. |
||||